💰 Earnings Spotlight (Sept 29 – Oct 3, 2025)

• Nike (NKE): CSPs for entry; verticals if IV spikes.
• Carnival (CCL): Covered calls to capture post‑earnings premium.
• Conagra (CAG) / Cal‑Maine (CALM): Dividends + covered calls for carry.
• RPM (RPM) / Paychex (PAYX): CSPs near technical support.

Scope & Mechanics: A lapse in appropriations triggers furloughs for “non‑excepted” federal workers while essential services continue. Agencies publish contingency plans outlining what stays open (e.g., national security, air traffic control) and what pauses (e.g., some permitting, grants, visitor services).

• Agencies most visible to markets: BLS, BEA, and Census may delay data; SEC/CFTC/FTC/DOJ casework cadence can slow; USDA/Interior see curtailed public‑facing services.
• Furlough count: Often hundreds of thousands of workers; Congress has historically granted retroactive pay, but cash‑flow timing can weigh on local spending.
• Data blackout risk: NFP, GDP updates, retail sales, and housing can slip. The Fed continues publishing its own materials (independent funding).
• GDP & confidence: A longer lapse dampens confidence/government demand; headline GDP effects usually recover after back pay, but sentiment can lag.
• Market history: 2013 and 2018–19 episodes brought near‑term volatility with limited lasting damage; length and data gaps mattered most.
• Positioning: Prefer defined‑risk option structures, modest tail hedges (gold), and reduced exposure to new‑award‑dependent contractors until clarity returns.

Deal Tape: Tracking large‑cap healthcare, tech, and energy transactions for both spread capture and sector read‑throughs.

• Regulatory cadence: FTC/DOJ second requests and court calendars drive timing; cross‑border deals add EC/CMA review complexity.
• Arb spreads: Widen on antitrust or financing uncertainty; compress on consent decrees or constructive court signals.
• Funding mix: Cash‑heavy deals sensitive to credit markets; equity‑heavy deals hinge on buyer stock and collars.
• Peer impact: Consolidation can rerate peers (scarcity value) while suppliers/customers face synergy‑driven pricing pressure.
• QBH tactics: Prefer baskets over single‑name concentration; scale position around milestones (HSR, remedies, hearings); avoid crowded arb into binary rulings.

Leaders: Quality mega‑cap growth and AI‑adjacent software on resilient margins; staples bid on policy uncertainty; travel & leisure lead on firm bookings and easing fuel.

• Winners (illustrative): Select large‑cap platforms; dividend staples with pricing power; gold miners on policy risk hedging.
• Rotation tells: Tilt toward profitability/quality; equal‑weight lags if small caps soften.

Laggards: Rate‑sensitive utilities when yields back up; unprofitable tech under higher risk premia; certain small‑cap cyclicals on growth jitters.

• Losers (illustrative): Spec biotech without catalysts; stretched discretionary if guidance weakens; levered balance sheets under higher‑for‑longer rates.
• Options color: Elevated skew around data windows favors spreads over naked premium; monitor dealer gamma flips near key index levels.

Note: Movers are for framing during the current macro week. Confirm exact performance with your data source before trading.